Cargando…

Frequency of laboratory measurement and hyperkalaemia in hospitalised patients using serum potassium concentration increasing drugs

PURPOSE: Although, drug–drug interactions (DDIs) between potassium-increasing drugs (PIDs) are known risk factors for developing hyperkalaemia, not much is known about their risk and management strategies during hospitalisation. This study examines the frequency of serum potassium measurements and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uijtendaal, Esther V., Zwart-van Rijkom, Jeannette E. F., van Solinge, Wouter W., Egberts, Toine C. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Pharmacoepidemiology and Prescription
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154285/ https://www.ncbi.nlm.nih.gov/pubmed/21424384 http://dx.doi.org/10.1007/s00228-011-1028-1

Ejemplares similares

Influence of a strict glucose protocol on serum potassium and glucose concentrations and their association with mortality in intensive care patients
por: Uijtendaal, Esther V., et al.
Publicado: (2015)

Dopamine agonists and ischemic complications in Parkinson’s disease: a nested case–control study
por: Arbouw, Maurits E. L., et al.
Publicado: (2011)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Evaluation of patients’ experiences with antidepressants reported by means of a medicine reporting system
por: van Geffen, E. C. G., et al.
Publicado: (2007)

Hospitalisations related to benzodiazepine, Z-drug, and opioid treatment in Italy: a claim on the risks associated with inappropriate use
por: Mattioli, Irene, et al.
Publicado: (2022)

The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports
por: Derijks, Hieronymus J., et al.
Publicado: (2008)

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands
por: van Hunsel, Florence, et al.
Publicado: (2010)

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study
por: Härmark, Linda, et al.
Publicado: (2012)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe
por: Ebbers, Hans C., et al.
Publicado: (2015)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study
por: van de Garde, Ewoudt MW, et al.
Publicado: (2007)

Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia
por: Sanders, L. M. J., et al.
Publicado: (2017)

Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study
por: van Uden, Renate C. A. E., et al.
Publicado: (2021)

Ten years after the Dutch public health campaign on folic acid: the continuing challenge
por: de Walle, Hermien E. K., et al.
Publicado: (2008)

Defining antimicrobial prescribing quality indicators: what is a new prescription?
por: Boesten, Jos, et al.
Publicado: (2010)

Are multidose drug dispensing systems initiated for the appropriate patients?
por: Mertens, Bram J., et al.
Publicado: (2018)

The nocebo effect challenges the non-medical infliximab switch in practice
por: Boone, N. W., et al.
Publicado: (2018)

Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients
por: van Orten-Luiten, A. C. B., et al.
Publicado: (2016)

Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents
por: Sodihardjo-Yuen, Fong, et al.
Publicado: (2016)

How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
por: Teichert, Martina, et al.
Publicado: (2007)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children
por: ter Horst, P. G. J., et al.
Publicado: (2012)

Switching from a traditional undergraduate programme in (clinical) pharmacology and therapeutics to a problem-based learning programme
por: Brinkman, David J., et al.
Publicado: (2020)

Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey
por: Jaspers, Tessa Corrine Catherina, et al.
Publicado: (2022)

Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP/START criteria v2: a longitudinal study
por: Damoiseaux-Volman, Birgit A., et al.
Publicado: (2020)

The use of driving impairing medicines: a European survey
por: Ravera, Silvia, et al.
Publicado: (2009)

A novel approach to teaching pharmacotherapeutics—feasibility of the learner-centered student-run clinic
por: Dekker, Ramon S., et al.
Publicado: (2015)

Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists
por: van Hoorn, Camille E., et al.
Publicado: (2020)

Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework
por: Li, Raymond, et al.
Publicado: (2022)

The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study
por: Reumerman, Michael O., et al.
Publicado: (2020)

EurOP(2)E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers
por: Bakkum, Michiel J., et al.
Publicado: (2021)

Medication administered to children from 0 to 7.5 years in the Avon Longitudinal Study of Parents and Children (ALSPAC)
por: Headley, J., et al.
Publicado: (2007)

Regulatory scientific advice in drug development: does company size make a difference?
por: Putzeist, Michelle, et al.
Publicado: (2010)

Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?
por: Grimmsmann, Thomas, et al.
Publicado: (2011)

Pharmacovigilance in children in Camagüey Province, Cuba
por: Bárzaga Arencibia, Z., et al.
Publicado: (2012)

Effects of codeine on pregnancy outcome: results from a large population-based cohort study
por: Nezvalová-Henriksen, Kateřina, et al.
Publicado: (2011)

Systematic review of safety in paediatric drug trials published in 2007
por: Nor Aripin, Khairun Nain Bin, et al.
Publicado: (2011)

Appropriateness of treatment recommendations for PPI in hospital discharge letters
por: Ahrens, Dirk, et al.
Publicado: (2010)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ndnbcltnbjvlhkpj4g81imocci